NCT03609827View on ClinicalTrials.gov

Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

September 1, 2015

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2021

Conditions
Hematologic MalignanciesNonmalignant DiseasesImmunodeficienciesHemoglobinopathiesGenetic Inborn Errors of MetabolismFanconi's AnemiaThalassemiaSickle Cell Disease
Interventions
DRUG

Melphalan

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT03609827 - Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients | Biotech Hunter | Biotech Hunter